Months after cancer drug trial, Merus agrees to be bought at 41% premium

1 month ago 49
Merus agreed to be bought for a 41% premium, months after a positive trial of a cancer drug.
Read Entire Article
  1. Homepage
  2. category-label-
  3. Months after cancer drug trial, Merus agrees to be bought at 41% premium

Related

U.S. stock futures inch higher as Wall Street looks to extend winning streak in November

U.S. stock futures inch higher as Wall Street looks to exten...

7 hours ago 3
OPEC+ to pause output hikes in first quarter to ease fears of glut, after one more boost in December

OPEC+ to pause output hikes in first quarter to ease fears o...

9 hours ago 3
Is Big Tech’s soaring AI spending creating a bubble? Here’s what it means for stocks.

Is Big Tech’s soaring AI spending creating a bubble? Here’s ...

13 hours ago 5

Trending

Popular

Asia Morning Briefing: What's the Real Use for a Yen Stablecoin? An On-Chain Carry Trade

Asia Morning Briefing: What's the Real Use for a Yen Stablec...

4 days ago 71
Bitchat hits No. 2 on app charts in Jamaica as Hurricane Melissa strikes

Bitchat hits No. 2 on app charts in Jamaica as Hurricane Mel...

4 days ago 65
The Protocol: ETH’s Fusaka Upgrade Goes Live on Hoodi, Mainnet Next

The Protocol: ETH’s Fusaka Upgrade Goes Live on Hoodi, Mainn...

4 days ago 46
Indonesia’s digital rupiah CBDC to get stablecoin twist with government bond backing

Indonesia’s digital rupiah CBDC to get stablecoin twist with...

3 days ago 45
Crypto Stocks Climb Alongside Bitcoin and Nasdaq on Chinese Trade Talk Optimism

Crypto Stocks Climb Alongside Bitcoin and Nasdaq on Chinese ...

6 days ago 44
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Tayedi Search engine 2025. All rights are reserved